Latest Capital Markets News

Deterra Royalties reported a 10% rise in quarterly revenue driven by iron ore royalties and gold offtakes, completed a US$82 million sale of non-core assets, and marked progress on the Thacker Pass lithium project amid leadership changes.

Elixinol Wellness Limited (ASX – EXL) has launched a substantial options offer to placement investors and its lead manager, pending shareholder approval. The offer could reshape the company’s capital structure and potentially raise $4.4 million upon exercise.

I Synergy Group Limited has formalised a strategic AI infrastructure agreement with Treasure Global Inc. and launched a partnership with Octagram Investment Limited, signalling early moves into AI-powered digital technologies.

Locate Technologies has ended its Australian ATM Facility, initiated a new NZ$10 million facility in New Zealand, and proposed a share buy-back pending shareholder approval, aligning with its Bitcoin Treasury ambitions.

Kaiser Reef reports record gold production at Henty, extends mine life beyond six years, and advances exploration at Maldon, while transitioning A1 mine to care and maintenance.

Bioxyne Limited has reported a record-breaking first quarter for FY26, with revenues soaring 210% year-on-year, driven by strong demand in cannabis products and strategic European market advances.

Culpeo Minerals reported a challenging quarter with cash outflows from operations and investing, offset by financing inflows, leaving under one quarter of funding available. The company is actively reviewing capital raising options to maintain its exploration activities.

Lakes Blue Energy marked a pivotal quarter with its ASX reinstatement, a $5.8 million capital raise, and completion of the Wombat-5 well, setting the stage for imminent production testing and resource upgrades.

Trigg Minerals has initiated the process for a Nasdaq dual listing via an American Depositary Receipt program, aiming to tap into the world’s largest capital market. The company also raised A$2.5 million from Tribeca Investment Partners, reinforcing its growth strategy.

Patrys Limited has raised $1.77 million through a fully underwritten entitlement offer to fund preclinical studies and business development for its deoxymab therapeutic antibodies. The company also completed a capital consolidation and held a successful AGM, signaling a strategic pivot into immunology and inflammation.

Southern Palladium has cleared major regulatory hurdles and confirmed robust economics for its Bengwenyama platinum group metals project, supported by a $20 million capital raise to fund next-stage development.

D3 Energy has secured formal acceptance of its Production Right Application for the ER315 permit in South Africa, marking a pivotal step toward production. The company also broadened its portfolio with new helium and hydrogen permits in Australia and began trading on the US OTCQX market.